SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Blueprint Medicines Corporation (BPMC)

BPMC RSS Feed
Add BPMC Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 6/5/2016 12:43:36 PM - Followers: 4 - Board type: Free - Posts Today: 0
Blueprint Medicines is a patient-driven oncology company developing highly selective kinase inhibitors for genomically defined cancer subsets. Led by a management team and advisors with world-renowned expertise in cancer genomics, drug discovery and clinical oncology, Blueprint has developed a platform that combines genomics with a novel library of kinase inhibitors, enabling Blueprint to rapidly develop potent highly selective compounds against clear genomic driver targets.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BPMC
Current Price
Volume:
Bid Ask Day's Range
SureTrader
BPMC News: Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock 06:44 PM
BPMC News: Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock 12/06/2016 04:26:00 PM
BPMC News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 12/06/2016 04:19:00 PM
BPMC News: Current Report Filing (8-k) 12/05/2016 09:07:27 AM
BPMC News: Statement of Changes in Beneficial Ownership (4) 12/05/2016 06:23:31 AM
News News Alert: Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock 12/07/2016 06:44:00 PM